Diabetes and obesity pills a step closer
New research highlights the use of a new small molecule drug class as oral therapies for diabetes and obesity.
Archives for January 26, 2007
Smokers quit after brain damage
A heavy smoker who suffered brain damage and promptly 'forgot the urge to smoke' could unravel the mysteries of addiction and provide scientists with a new strategy for designing anti-smoking drugs.
Coley suspends Hepatitis C drug development
Coley Pharmaceutical has decided to suspend development of its Hepatitis C drug and will instead concentrate on other innovative drugs designed to activate the immune system.
PerkinElmer increases R&D spending
Increased research and development (R&D) spending masks strong revenue growth by PerkinElmer's life and analytical sciences division.
Pharma sales fuel Waters resurgence
Waters posted an 11 per cent yearly sales increase on the back of increasing demand from the pharmaceutical industry, generic houses and outsourcing laboratories.